Largest biotechnology: pharmaceutical preparations companies — Page 4
Every US-listed biotechnology: pharmaceutical preparations company we cover, 500 of them, ranked by market capitalisation, with revenue and earnings taken from their SEC filings.
Combined market cap
$5.202 T
5.3% of all US-listed value
Companies
500
Ranked #5 of 152 industries
Average
$10.404 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 301 | Anixa BiosciencesANIX | $94.2M | $2.71 | +1.12% | United States |
| 302 | GeneluxGNLX | $93.7M | $2.07 | -17.20% | United States |
| 303 | OnKure TherapeuticsOKUR | $93.1M | $2.30 | -2.54% | United States |
| 304 | Tonix PharmaceuticalsTNXP | $93.1M | $5.43 | -6.05% | United States |
| 305 | EquilliumEQ | $90.0M | $1.42 | +2.90% | United States |
| 306 | Quantum CyberQUCY | $89.0M | $1.02 | -4.67% | Germany |
| 307 | Milestone PharmaceuticalsMIST | $86.6M | $0.70 | -3.23% | Canada |
| 308 | Neonc TechnologiesNTHI | $86.3M | $2.90 | +4.69% | United States |
| 309 | RallybioRLYB | $86.1M | $16.22 | -0.98% | United States |
| 310 | Rani TherapeuticsRANI | $84.3M | $0.61 | -7.32% | United States |
| 311 | Corbus PharmaceuticalsCRBP | $82.9M | $4.29 | -3.05% | United States |
| 312 | Inovio PharmaceuticalsINO | $82.2M | $0.80 | -21.26% | United States |
| 313 | ProMIS NeurosciencesPMN | $81.9M | $9.13 | +12.86% | Canada |
| 314 | Acrivon TherapeuticsACRV | $78.2M | $1.83 | +1.67% | United States |
| 315 | Telomir PharmaceuticalsTELO | $75.1M | $1.02 | +0.99% | United States |
| 316 | LifevantageLFVN | $74.9M | $5.95 | -0.34% | United States |
| 317 | MAIA BiotechnologyMAIA | $70.4M | $1.14 | +1.79% | United States |
| 318 | MedicinovaMNOV | $69.4M | $1.41 | +3.68% | United States |
| 319 | Zhengye BiotechnologyZYBT | $69.2M | $1.46 | -2.01% | China |
| 320 | Spero TherapeuticsSPRO | $68.1M | $1.17 | -4.10% | United States |
| 321 | CingulateCING | $67.8M | $4.66 | +2.87% | United States |
| 322 | RafaelRFL | $67.6M | $1.30 | +0.78% | United States |
| 323 | Oncolytics BiotechONCY | $67.1M | $0.51 | +2.57% | Canada |
| 324 | IntercureINCR | $66.3M | $4.42 | -0.23% | Israel |
| 325 | OS TherapiesOSTX | $66.0M | $1.27 | +0.79% | United States |
| 326 | Citius OncologyCTOR | $65.1M | $0.70 | +4.37% | United States |
| 327 | Fortress BiotechFBIO | $64.7M | $1.94 | +0.00% | United States |
| 328 | Heron TherapeuticsHRTX | $64.3M | $0.34 | -4.43% | United States |
| 329 | ApollomicsAPLM | $62.5M | $21.59 | -2.06% | United States |
| 330 | Verrica PharmaceuticalsVRCA | $62.4M | $3.63 | +4.61% | United States |
| 331 | Tenax TherapeuticsTENX | $61.0M | $1.63 | +0.00% | United States |
| 332 | XBiotechXBIT | $60.7M | $1.99 | -1.49% | United States |
| 333 | Gossamer BioGOSS | $59.9M | $9.79 | +2.19% | United States |
| 334 | MindWalkHYFT | $59.8M | $1.27 | -1.55% | Canada |
| 335 | Stablecoin DevelopmentSDEV | $56.9M | $1.10 | +32.53% | United States |
| 336 | Nomad Power SolutionsNMAD | $56.8M | $3.53 | -5.11% | United States |
| 337 | Boundless BioBOLD | $56.4M | $2.44 | +0.41% | United States |
| 338 | TalpheraTLPH | $55.5M | $1.07 | +0.00% | United States |
| 339 | RenovoRxRNXT | $55.5M | $1.23 | +2.50% | United States |
| 340 | Xilio TherapeuticsXLO | $55.5M | $8.43 | -1.29% | United States |
| 341 | Pliant TherapeuticsPLRX | $54.9M | $0.89 | -2.92% | United States |
| 342 | iBioIBIO | $54.0M | $0.84 | +2.31% | United States |
| 343 | Rein TherapeuticsRNTX | $53.9M | $0.62 | +4.99% | United States |
| 344 | CleneCLNN | $53.4M | $3.76 | +0.80% | United States |
| 345 | Gain TherapeuticsGANX | $51.9M | $1.19 | +0.00% | United States |
| 346 | Connect BiopharmaCNTB | $50.3M | $0.80 | -8.81% | China |
| 347 | Werewolf TherapeuticsHOWL | $50.1M | $1.03 | -1.91% | United States |
| 348 | Biomea FusionBMEA | $50.0M | $0.69 | -6.18% | United States |
| 349 | Hyperion DefiHYPD | $47.9M | $3.10 | +4.20% | United States |
| 350 | Mereo BioPharma GroupMREO | $46.5M | $0.29 | -1.32% | United Kingdom |
| 351 | Elicio TherapeuticsELTX | $45.2M | $1.67 | +6.37% | United States |
| 352 | Serina TherapeuticsSER | $45.0M | $1.77 | +6.63% | United States |
| 353 | Alterity TherapeuticsATHE | $43.5M | $2.39 | +0.84% | Australia |
| 354 | Actinium PharmaceuticalsATNM | $43.4M | $1.38 | -1.43% | United States |
| 355 | Annovis BioANVS | $42.4M | $0.99 | +1.52% | United States |
| 356 | Adicet BioACET | $42.0M | $4.49 | -0.66% | United States |
| 357 | Grace TherapeuticsGRCE | $41.4M | $1.97 | -0.51% | Canada |
| 358 | Aldeyra TherapeuticsALDX | $40.4M | $0.67 | -8.72% | United States |
| 359 | Dogwood TherapeuticsDWTX | $39.8M | $1.17 | +1.74% | United States |
| 360 | VeruVERU | $39.2M | $2.30 | -3.36% | United States |
| 361 | NanoviricidesNNVC | $38.5M | $1.51 | +2.03% | United States |
| 362 | Edesa BiotechEDSA | $38.5M | $2.85 | +1.06% | United States |
| 363 | Lite StrategyLITS | $37.7M | $1.24 | +4.20% | United States |
| 364 | ScynexisSCYX | $37.7M | $3.79 | -0.40% | United States |
| 365 | Nasus PharmaNSRX | $35.8M | $3.06 | -5.56% | Israel |
| 366 | CervoMedCRVO | $35.4M | $2.34 | +2.18% | United States |
| 367 | GridAI TechnologiesGRDX | $34.9M | $4.90 | +5.83% | United States |
| 368 | Incannex HealthcareIXHL | $34.6M | $2.76 | +0.53% | Australia |
| 369 | Impact BiomedicalIBO | $34.3M | $4.02 | +23.03% | United States |
| 370 | CelularityCELU | $33.1M | $1.02 | -19.05% | United States |
| 371 | Filana TherapeuticsFLNA | $31.8M | $0.66 | -4.24% | United States |
| 372 | BriaCell TherapeuticsBCTX | $31.3M | $3.60 | +4.05% | Canada |
| 373 | China PharmaCPHI | $30.0M | $0.70 | -3.78% | China |
| 374 | Mira PharmaceuticalsMIRA | $28.7M | $0.68 | +4.88% | United States |
| 375 | Rockwell MedicalRMTI | $28.5M | $7.08 | -2.08% | United States |
| 376 | Transcode TherapeuticsRNAZ | $28.1M | $1.66 | -1.19% | United States |
| 377 | Abvc BiopharmaABVC | $26.7M | $1.00 | +7.53% | United States |
| 378 | Atossa TherapeuticsATOS | $25.2M | $2.53 | -0.39% | United States |
| 379 | IGC PharmaIGC | $25.1M | $0.24 | -1.02% | United States |
| 380 | NextCureNXTC | $24.8M | $5.42 | -0.46% | United States |
| 381 | ImmutepIMMP | $24.2M | $3.28 | +0.61% | Australia |
| 382 | Psyence BiomedicalPBM | $24.0M | $4.52 | +6.60% | Canada |
| 383 | Seres TherapeuticsMCRB | $23.1M | $2.30 | -0.43% | United States |
| 384 | Shuttle PharmaceuticalsSHPH | $23.0M | $4.82 | -1.83% | United States |
| 385 | TherapeuticsMDTXMD | $22.0M | $1.90 | +1.06% | United States |
| 386 | Aytu BiopharmaAYTU | $21.3M | $1.96 | -2.49% | United States |
| 387 | Context TherapeuticsCNTX | $21.3M | $0.23 | -5.09% | United States |
| 388 | Kyntra BioKYNB | $21.1M | $5.21 | -1.33% | United States |
| 389 | Universe PharmaceuticalsUPC | $21.1M | $4.19 | +18.02% | China |
| 390 | BeyondSpringBYSI | $20.4M | $0.50 | -5.13% | United States |
| 391 | Quantum BiopharmaQNTM | $20.3M | $2.40 | -1.24% | Canada |
| 392 | Optimi HealthOPTH | $20.2M | $3.53 | +5.06% | Canada |
| 393 | Akari TherapeuticsAKTX | $20.0M | $8.76 | -5.71% | United Kingdom |
| 394 | Quoin PharmaceuticalsQNRX | $19.2M | $3.99 | -1.24% | Israel |
| 395 | Marker TherapeuticsMRKR | $18.8M | $1.13 | -2.59% | United States |
| 396 | Neuphoria TherapeuticsNEUP | $18.8M | $3.48 | +2.65% | United States |
| 397 | Cocrystal PharmaCOCP | $18.2M | $0.94 | +0.07% | United States |
| 398 | Jaguar HealthJAGX | $17.8M | $2.28 | -13.31% | United States |
| 399 | NewcelXNCEL | $17.0M | $2.95 | +13.03% | Switzerland |
| 400 | Pasithea TherapeuticsKTTA | $16.3M | $0.49 | +18.98% | United States |
Showing 301–400 of 500 companies. One row per company, with secondary share classes folded into their primary listing. Updated 23 Oct 2026.
Sectors biotechnology: pharmaceutical preparations companies sit in
Other industries
Semiconductors 100Computer Software: Programming Data Processing 77Computer Software: Prepackaged Software 233Computer Manufacturing 10Major Banks 243Industrial Machinery/Components 210Catalog/Specialty Distribution 30Business Services 92Commercial Banks 35Integrated oil Companies 16Auto Manufacturing 29Oil & Gas Production 116Investment Bankers/Brokers/Service 69Department/Specialty Retail Stores 13Real Estate Investment Trusts 175Beverages (Production/Distribution) 36Telecommunications Equipment 84Electric Utilities: Central 61Finance: Consumer Services 165Electronic Components 20Biotechnology: Biological Products (No Diagnostic Substances) 162Medical Specialities 44Consumer Electronics/Appliances 23Property-Casualty Insurers 68All industries →
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.